NF1 c.5998C>G ;(p.L2000V)

Variant ID: 17-29662041-C-G

NM_001042492.2(NF1):c.5998C>G;(p.L2000V)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Molecular pathways, resistance mechanisms and targeted interventions in non-small-cell lung cancer.

Molecular Biomedicine
Wang, Zixi Z; Xing, Yurou Y; Li, Bingjie B; Li, Xiaoyu X; Liu, Bin B; Wang, Yongsheng Y
Publication Date: 2022-12-12

Variant appearance in text: NF1: L2000V
PubMed Link: 36508072
Variant Present in the following documents:
  • Main text
  • 43556_2022_Article_107.pdf
View BVdb publication page



Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in ROS1 Fusion-Positive Lung Cancer.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Lin, Jessica J JJ; Choudhury, Noura J NJ; Yoda, Satoshi S; Zhu, Viola W VW; Johnson, Ted W TW; Sakhtemani, Ramin R; Dagogo-Jack, Ibiayi I; Digumarthy, Subba R SR; Lee, Charlotte C; Do, Andrew A; Peterson, Jennifer J; Prutisto-Chang, Kylie K; Malik, Wafa W; Hubbeling, Harper G HG; Langenbucher, Adam A; Schoenfeld, Adam J AJ; Falcon, Christina J CJ; Temel, Jennifer S JS; Sequist, Lecia V LV; Yeap, Beow Y BY; Lennerz, Jochen K JK; Shaw, Alice T AT; Lawrence, Michael S MS; Ou, Sai-Hong Ignatius SI; Hata, Aaron N AN; Drilon, Alexander A; Gainor, Justin F JF
Publication Date: 2021-05-15

Variant appearance in text: NF1: L2000V
PubMed Link: 33685866
Variant Present in the following documents:
  • Main text
View BVdb publication page



ROS1-dependent cancers - biology, diagnostics and therapeutics.

Nature Reviews. Clinical Oncology
Drilon, Alexander A; Jenkins, Chelsea C; Iyer, Sudarshan S; Schoenfeld, Adam A; Keddy, Clare C; Davare, Monika A MA
Publication Date: 2021-01

Variant appearance in text: NF1: L2000V
PubMed Link: 32760015
Variant Present in the following documents:
  • Main text
View BVdb publication page